Cargando…

Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn’s disease

INTRODUCTION: Anti-tumor necrosis factor (TNF) dose intensification represents an effective method of overcoming secondary loss of response (LOR); however, a subset of patients may not respond (tertiary non-response), or fail to demonstrate durable response (tertiary LOR) to intensified dosing. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinivasan, Ashish, Gilmore, Robert, van Langenberg, Daniel, De Cruz, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814980/ https://www.ncbi.nlm.nih.gov/pubmed/35126667 http://dx.doi.org/10.1177/17562848211070940

Ejemplares similares

Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn’s disease patients with secondary loss of response
por: Kim, Eun Sil, et al.
Publicado: (2023)

Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
por: Xiao, Teresa L., et al.
Publicado: (2022)

Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis
por: Guberna, Laura, et al.
Publicado: (2021)

PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN’S DISEASE
por: dos SANTOS, Byanca Rossetti Moreira, et al.
Publicado: (2020)

Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab
por: Roblin, Xavier, et al.
Publicado: (2015)

Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn’s disease: a retrospective chart review
por: Do, Phinga, et al.
Publicado: (2021)

Systematic review: genetic biomarkers associated with anti‐TNF treatment response in inflammatory bowel diseases
por: Bek, S., et al.
Publicado: (2016)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
por: Chaparro, María, et al.
Publicado: (2019)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Bohra, Anuj, et al.
Publicado: (2023)

Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer
por: Clifford, R., et al.
Publicado: (2018)

Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease
por: Kwak, Min Seob, et al.
Publicado: (2022)

Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in crohn’s disease
por: Ye, Chenglin, et al.
Publicado: (2022)

MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease
por: Feng, Jing, et al.
Publicado: (2022)

A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn’s Disease
por: Chen, Yueying, et al.
Publicado: (2021)

Intensification or diversification: responses by anti health-pass entrepreneurs to French government announcements
por: Lévêque, Christophe, et al.
Publicado: (2023)

Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
por: Bokemeyer, Arne, et al.
Publicado: (2018)

MIF Variant rs755622 Is Associated with Severe Crohn’s Disease and Better Response to Anti-TNF Adalimumab Therapy
por: Jezernik, Gregor, et al.
Publicado: (2023)

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2023)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Transcriptomic response to aquaculture intensification in Nile tilapia
por: Rodriguez‐Barreto, Deiene, et al.
Publicado: (2019)

Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
por: Rostami-Nejad, Mohammad, et al.
Publicado: (2023)

Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn’s disease naive to anti-TNF agents
por: Eder, Piotr, et al.
Publicado: (2015)

Health-care professionals' responsibility to patients' relatives in genetic medicine: a systematic review and synthesis of empirical research
por: Dheensa, Sandi, et al.
Publicado: (2016)

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
por: Walczak, Michal, et al.
Publicado: (2020)

Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFα Treatment in Crohn’s Disease
por: de Voogd, F, et al.
Publicado: (2022)

Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose–Response Meta-analysis
por: Pitre, Tyler, et al.
Publicado: (2023)

Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
por: Mazhar, Faizan, et al.
Publicado: (2020)

Systematic review of statins in sepsis: There is no evidence of dose response
por: Quinn, Morgan, et al.
Publicado: (2016)

Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017)

Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
por: Chiba, Toshimi, et al.
Publicado: (2019)

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
por: Boronat-Toscano, Albert, et al.
Publicado: (2022)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

The Effects of Acupuncture on Crohn’s Disease: a systematic review and meta-analysis
por: Bae, Joon Hyun, et al.
Publicado: (2023)

Atrial fibrillation burden and the risk of stroke: A systematic review and dose-response meta-analysis
por: Yang, Sheng-Yi, et al.
Publicado: (2022)

Time Spent on Social Media and Risk of Depression in Adolescents: A Dose–Response Meta-Analysis
por: Liu, Mingli, et al.
Publicado: (2022)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Dose–Response Relationships of Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis
por: Borde, Ron, et al.
Publicado: (2015)

Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis
por: Pitre, Tyler, et al.
Publicado: (2023)

Evaluation of ileal Crohn’s disease response to TNF antagonists: Validation of MR enterography for assessing response. Initial results
por: Gordic, Sonja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_854m662fmrud4aq4t9fec1caqu